Search results for 2)

HSV-2/HHV-2 gC/UL44 ELISA Kit, ProteoGenix, KPTX447

Description of HSV-2/HHV-2 gC/UL44 ELISA Kit Introduction HSV-2/HHV-2, also known as herpes simplex virus type 2 or human herpesvirus type 2, is a highly infectious virus that primarily affects the genital area. It is one of the most common sexually transmitted infections, with an estimated 417 million people worldwide living with the virus. HSV-2 can cause painful genital sores and is also associated with an increased risk of HIV transmission. Therefore, accurate and reliable detection of HSV-2 is crucial for both diagnosis and management of the infection. Therapeutic Target The glycoprotein C (gC) and UL44 proteins of HSV-2 are important targets for therapeutic interventions. gC is a surface protein that plays a key role in viral attachment and entry into host cells. It also helps in evading the host immune response. UL44, on the other hand, is a DNA-binding protein that is essential for viral replication. Inhibition of these proteins can potentially prevent viral spread and reduce the severity of HSV-2 infections. Structure of HSV-2/HHV-2 gC/UL44 The HSV-2/HHV-2 gC/UL44 ELISA Kit is designed to detect the presence of antibodies against these two proteins in human serum or plasma samples. The kit contains pre-coated microplates with gC and UL44 antigens, as well as controls and reagents for the detection of specific antibodies. The gC antigen is a recombinant protein derived from the gC gene of HSV-2, while the UL44 antigen is a synthetic peptide corresponding to a highly conserved region of the UL44 protein. ELISA Principle The enzyme-linked immunosorbent assay (ELISA) is a widely used technique for detecting and quantifying specific antibodies in biological samples. In the HSV-2/HHV-2 gC/UL44 ELISA Kit, the microplate wells are coated with gC and UL44 antigens. When a sample containing antibodies against these antigens is added to the wells, the antibodies bind to the antigens. After washing away unbound components, an enzyme-linked secondary antibody is added, which binds to the bound antibodies. The addition of a substrate for the enzyme results in a color change, which is measured using a spectrophotometer. The intensity of the color is directly proportional to the amount of antibodies present in the sample. Applications The HSV-2/HHV-2 gC/UL44 ELISA Kit is primarily used for the diagnosis of HSV-2 infections. It can detect both primary and recurrent infections, as well as differentiate between HSV-1 and HSV-2 infections. The kit can also be used for monitoring the effectiveness of antiviral therapy in patients with HSV-2 infections. In addition, the gC and UL44 antigens in the kit can be used as targets for the development of new therapeutic agents against HSV-2. Research Use The HSV-2/HHV-2 gC/UL44 ELISA Kit is also widely used in research studies to investigate the prevalence and epidemiology of HSV-2 infections. It can provide valuable information on the spread of the virus and risk factors associated with infection. The kit can also be used to study the immune response to HSV-2 and evaluate the effectiveness of potential vaccines. Conclusion The HSV-2/HHV-2 gC/UL44 ELISA Kit is a reliable and sensitive tool for the detection of antibodies against gC and UL44 proteins of HSV-2. Its use in clinical and research settings has contributed significantly to the understanding and management of HSV-2 infections. The gC and UL44 proteins also hold promise as therapeutic targets for the development of new treatments for HSV-2.

HSV-2/HHV-2 gD/US6 ELISA Kit, ProteoGenix, KPTX449

Description of HSV-2/HHV-2 gD/US6 ELISA Kit Introduction The HSV-2/HHV-2 gD/US6 ELISA Kit is a cutting-edge diagnostic tool used in the detection and quantification of antibodies against the glycoprotein D (gD) and US6 proteins of Herpes Simplex Virus-2 (HSV-2) and Human Herpesvirus-2 (HHV-2). This highly sensitive and specific test is based on the principle of Enzyme-Linked Immunosorbent Assay (ELISA) and is widely used in both research and clinical settings for the diagnosis and monitoring of HSV-2/HHV-2 infections. Structure of the Kit The HSV-2/HHV-2 gD/US6 ELISA Kit is composed of a 96-well microplate coated with purified gD and US6 antigens, along with all the necessary reagents and controls. The kit also includes a set of standard samples with known concentrations of anti-gD and anti-US6 antibodies, which are used to generate a standard curve for the quantification of the test sample. Activity of the Kit The ELISA procedure involves the binding of anti-gD and anti-US6 antibodies present in the test sample to the coated antigens on the microplate. After a series of washing steps to remove any unbound antibodies, an enzyme-labeled secondary antibody is added to the plate. This secondary antibody binds to the primary antibodies, forming an antigen-antibody-enzyme complex. The addition of a substrate for the enzyme results in a color change, which is measured by a spectrophotometer. The intensity of the color is directly proportional to the amount of anti-gD and anti-US6 antibodies present in the sample, allowing for the quantification of these antibodies. Application of the Kit The HSV-2/HHV-2 gD/US6 ELISA Kit has a wide range of applications, including: Diagnosis of HSV-2/HHV-2 Infections: This kit is a valuable tool for the diagnosis of active or past infections with HSV-2/HHV-2. The presence of anti-gD and anti-US6 antibodies in the test sample indicates a current or previous infection with these viruses, making it an essential diagnostic tool for healthcare professionals. Monitoring the Efficacy of Treatment: The HSV-2/HHV-2 gD/US6 ELISA Kit can also be used to monitor the response to treatment in patients with HSV-2/HHV-2 infections. A decrease in the levels of anti-gD and anti-US6 antibodies in the test sample indicates a successful response to treatment. Research Use: This kit is widely used in research studies to investigate the prevalence and epidemiology of HSV-2/HHV-2 infections. It is also used to study the immune response to these viruses and to evaluate the effectiveness of potential vaccines and therapeutic agents. Therapeutic Target: The gD and US6 proteins of HSV-2/HHV-2 are potential therapeutic targets for the development of antiviral drugs and vaccines. The HSV-2/HHV-2 gD/US6 ELISA Kit is an essential tool for the identification and validation of these targets, aiding in the development of effective treatments for HSV-2/HHV-2 infections. Conclusion The HSV-2/HHV-2 gD/US6 ELISA Kit is a reliable and sensitive diagnostic tool for the detection and quantification of anti-gD and anti-US6 antibodies in HSV-2/HHV-2 infections. Its wide range of applications, including diagnosis, treatment monitoring, and research use, make it an essential tool for healthcare professionals and researchers alike. Furthermore, the gD and US6

HSV-2/HHV-2 gG/US4 ELISA Kit, ProteoGenix, KPTX448

Description of HSV-2/HHV-2 gG/US4 ELISA Kit Introduction The HSV-2/HHV-2 gG/US4 ELISA Kit is a highly sensitive and specific diagnostic tool used for the detection of antibodies against the herpes simplex virus type 2 (HSV-2) and human herpesvirus 2 (HHV-2) in human serum or plasma samples. This kit is based on the principle of enzyme-linked immunosorbent assay (ELISA) and is designed for research use and clinical diagnosis of HSV-2/HHV-2 infections. Structure of the Kit The HSV-2/HHV-2 gG/US4 ELISA Kit is composed of several components including microtiter plates coated with recombinant HSV-2/HHV-2 gG/US4 antigen, sample diluent, wash buffer, enzyme conjugate, substrate solution, and stop solution. The recombinant antigen used in this kit is a highly purified and specific protein derived from the glycoprotein G (gG) and unique short (US) region 4 of HSV-2/HHV-2, which is known to be the major target of the humoral immune response during infection. Working Principle The ELISA method is based on the specific binding of antibodies present in the sample to the immobilized antigen on the microtiter plate. During the first step, the sample is diluted with the sample diluent and added to the coated microtiter wells. If the sample contains antibodies against HSV-2/HHV-2, they will bind to the recombinant antigen on the plate. After washing to remove unbound components, an enzyme-conjugated anti-human IgG antibody is added, which will bind to the captured antibodies. The addition of a substrate solution will result in a color change, and the intensity of the color is directly proportional to the amount of antibodies present in the sample. Finally, the reaction is stopped, and the absorbance is measured using a spectrophotometer. Application of the Kit The HSV-2/HHV-2 gG/US4 ELISA Kit has several applications in the field of virology and infectious diseases. It is primarily used for the diagnosis of HSV-2/HHV-2 infections, which can cause genital herpes, neonatal herpes, and other serious complications in immunocompromised individuals. This kit can detect both IgG and IgM antibodies, making it useful for both acute and chronic infections. It is also used for screening blood donations to prevent the transmission of HSV-2/HHV-2 through blood transfusions. Therapeutic Target The glycoprotein G (gG) and unique short (US) region 4 of HSV-2/HHV-2, which are the main components of the recombinant antigen used in this kit, have been identified as potential therapeutic targets for the development of vaccines and antiviral drugs. These proteins are known to play a crucial role in the entry and spread of the virus in the host cells, making them attractive targets for therapeutic interventions. Research Use Apart from its clinical applications, the HSV-2/HHV-2 gG/US4 ELISA Kit is also widely used in research studies to investigate the epidemiology, pathogenesis, and immune response of HSV-2/HHV-2 infections. It allows for the detection of specific antibodies in large populations, providing valuable information about the prevalence and risk factors associated with these infections. The kit has also been used to evaluate the efficacy of potential vaccines and antiviral agents in preclinical studies. Conclusion In summary, the HSV-2/HHV-2 gG/US4 ELISA Kit is a reliable and sensitive tool for the detection of antibodies against HSV-2/HHV-2. Its use in clinical diagnosis and research has greatly contributed to our understanding of these viruses and has the potential to aid in the development of effective treatments. With its simple procedure, high specificity,

HSV-2/HHV-2 US8/gE ELISA Kit, ProteoGenix, KPTX450

Description of HSV-2/HHV-2 US8/gE ELISA Kit Introduction HSV-2/HHV-2 US8/gE ELISA Kit is a highly sensitive and specific diagnostic tool used for the detection of antibodies against the glycoprotein E (gE) of Herpes Simplex Virus 2 (HSV-2) or Human Herpes Virus 2 (HHV-2). This kit utilizes the enzyme-linked immunosorbent assay (ELISA) technique, which is widely used in research and clinical settings for the detection of various biomarkers. In this article, we will provide a detailed description of the structure, activity, and applications of HSV-2/HHV-2 US8/gE ELISA Kit. Structure of HSV-2/HHV-2 US8/gE ELISA Kit HSV-2/HHV-2 US8/gE ELISA Kit is composed of several components, including 96-well microtiter plates, HSV-2/HHV-2 US8/gE antigen, enzyme-conjugated anti-human IgG antibodies, and a chromogenic substrate. The microtiter plates are coated with the HSV-2/HHV-2 US8/gE antigen, which is a recombinant protein derived from the gE glycoprotein of HSV-2/HHV-2. The antigen is immobilized on the surface of the microtiter wells, allowing for the specific binding of antibodies present in the sample. Activity of HSV-2/HHV-2 US8/gE ELISA Kit HSV-2/HHV-2 US8/gE ELISA Kit works on the principle of antigen-antibody interaction. When a sample containing antibodies against HSV-2/HHV-2 US8/gE is added to the microtiter wells, the antibodies bind to the immobilized antigen. The wells are then washed to remove any unbound materials, and an enzyme-conjugated anti-human IgG antibody is added. This secondary antibody binds to the primary antibodies, forming an antigen-antibody-enzyme complex. After another round of washing, a chromogenic substrate is added, which reacts with the enzyme to produce a color change. The intensity of the color is directly proportional to the amount of antibodies present in the sample, and can be measured using a spectrophotometer. Applications of HSV-2/HHV-2 US8/gE ELISA Kit HSV-2/HHV-2 US8/gE ELISA Kit has multiple applications in both research and clinical settings. In research, this kit can be used to study the prevalence and seroprevalence of HSV-2/HHV-2 infections in different populations. It can also be used to monitor the immune response to HSV-2/HHV-2 infection and evaluate the effectiveness of vaccines or antiviral therapies. Furthermore, this kit can be used to screen potential therapeutic targets for the treatment of HSV-2/HHV-2 infections. In clinical settings, HSV-2/HHV-2 US8/gE ELISA Kit is used for the diagnosis of HSV-2/HHV-2 infections. It is particularly useful in cases where the virus cannot be isolated or cultured, such as in cases of latent or recurrent infections. This kit can also be used to differentiate between primary and recurrent infections, as well as to monitor the effectiveness of antiviral therapy. Additionally, HSV-2/HHV-2 US8/gE ELISA Kit can be used for prenatal screening to identify pregnant women at risk of transmitting the virus to their newborns. Therapeutic Target for HSV-2/HHV-2 Infections HSV-2/HHV-2 US8/gE is a potential therapeutic target for the treatment of HSV-2/HHV-2 infections. This glycoprotein plays a crucial role in viral entry and cell-to-cell spread, making it an attractive target for antiviral therapies. HSV-2/HHV-2 US8/gE ELISA Kit can be used to screen and evaluate potential inhibitors of this protein, which can potentially lead to the development of new treatments for HSV-2/HHV-

Biotin Anti-beta 2 Defensin/BD-2 antibody, Abcam, AB83509

Anti-NEDD4-2 (phospho S448) antibody [EPR8269(2)], Abcam, AB168349

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Adenine Nucleotide Translocator 2/ANT 2 antibody, Abcam, AB192410

Anti-Adenine Nucleotide Translocator 2/ANT 2 antibody, Abcam, AB222843

BAI1 Associated Protein 2 Like 2 (BAIAP2L2) Antibody, Abbexa, abx122473

Rabbit Polyclonal against the BAIAP2L2 protein.

Prothrombin Fragment 1+2 (F1+2) Antibody (Biotin), Abbexa, abx274599

Prothrombin Fragment 1+2 (F1+2) Antibody (Biotin) is a Mouse Monoclonal antibody conjugated to Biotin against Prothrombin Fragment 1+2 (F1+2).